ANNIE TRUONG: Open Payments
NPI 1386157642 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 22 payments from 9 companies in 2025. Trend: 2023 $2,732 · 2024 $903 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $114 |
| ABBVIE INC. | 4 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Incyte Corporation | 2 | $50 |
| EMD Serono, Inc. | 1 | $36 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| SHORLA ONCOLOGY INC. | 1 | $15 |
Products named: FRUZAQLA, EPKINLY, Nubeqa, ORGOVYX, PEMAZYRE, JAKAFI, TAVALISSE, DANZITEN.
Industry payments across CA — which companies pay providers there.
